Genetic Factors Affecting Late-Onset Alzheimer’s Disease Susceptibility

被引:0
|
作者
Maryam Rezazadeh
Aziz Khorrami
Tarlan Yeghaneh
Mahnaz Talebi
Seyed Jalal Kiani
Yaser Heshmati
Jalal Gharesouran
机构
[1] Tabriz University of Medical Sciences,Department of Medical Genetics, Faculty of Medicine
[2] Tabriz University of Medical Sciences,Neuroscience Research Center
[3] Tehran University of Medical Sciences,Virology Department, School of Public Health
[4] Karolinska Institutet,Department of Medicine, Huddinge, H7
来源
NeuroMolecular Medicine | 2016年 / 18卷
关键词
Alzheimer’s disease; Association; Polymorphism; Neurodegenerative diseases; Azeri Turkish;
D O I
暂无
中图分类号
学科分类号
摘要
Alzheimer’s disease is considered a progressive brain disease in the older population. Late-onset Alzheimer’s disease (LOAD) as a multifactorial dementia has a polygenic inheritance. Age, environment, and lifestyle along with a growing number of genetic factors have been reported as risk factors for LOAD. Our aim was to present results of LOAD association studies that have been done in northwestern Iran, and we also explored possible interactions with apolipoprotein E (APOE) status. We re-evaluated the association of these markers in dominant, recessive, and additive models. In all, 160 LOAD and 163 healthy control subjects of Azeri Turkish ethnicity were studied. The Chi-square test with Yates’ correction and Fisher’s exact test were used for statistical analysis. A Bonferroni-corrected p value, based on the number of statistical tests, was considered significant. Our results confirmed that chemokine receptor type 2 (CCR2), estrogen receptor 1 (ESR1), toll-like receptor 2 (TLR2), tumor necrosis factor alpha (TNFα), APOE, bridging integrator 1 (BIN1), and phosphatidylinositol-binding clathrin assembly protein (PICALM) are LOAD susceptibility loci in Azeri Turk ancestry populations. Among them, variants of CCR2, ESR1, TNFα, and APOE revealed associations in three different genetic models. After adjusting for APOE, the association (both allelic and genotypic) with CCR2, BIN1, and ESRα (PvuII) was evident only among subjects without the APOE ε4, whereas the association with CCR5, without Bonferroni correction, was significant only among subjects carrying the APOE ε4 allele. This result is an evidence of a synergistic and antagonistic effect of APOE on variant associations with LOAD.
引用
收藏
页码:37 / 49
页数:12
相关论文
共 50 条
  • [21] Environmental factors in the development and progression of late-onset Alzheimer’s disease
    Moses N. Wainaina
    Zhichun Chen
    Chunjiu Zhong
    [J]. Neuroscience Bulletin, 2014, 30 : 253 - 270
  • [22] Environmental factors in the development and progression of late-onset Alzheimer's disease
    Wainaina, Moses N.
    Chen, Zhichun
    Zhong, Chunjiu
    [J]. NEUROSCIENCE BULLETIN, 2014, 30 (02) : 253 - 270
  • [23] The genetics of late-onset Alzheimer's disease
    Myers, AJ
    Goate, AM
    [J]. CURRENT OPINION IN NEUROLOGY, 2001, 14 (04) : 433 - 440
  • [24] Cannabinoids in Late-Onset Alzheimer's Disease
    Ahmed, A. I. A.
    van der Marck, M. A.
    van den Elsen, G. A. H.
    Rikkert, M. G. M. Olde
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 (06) : 597 - 606
  • [25] The Role of Vascular Factors in Late-Onset Sporadic Alzheimer's Disease. Genetic and Molecular Aspects
    Rocchi, A.
    Orsucci, D.
    Tognoni, G.
    Ceravolo, R.
    Siciliano, G.
    [J]. CURRENT ALZHEIMER RESEARCH, 2009, 6 (03) : 224 - 237
  • [26] Late-Onset Alzheimer Disease
    Pierce, Aimee L.
    Bullain, Szofia S.
    Kawas, Claudia H.
    [J]. NEUROLOGIC CLINICS, 2017, 35 (02) : 283 - +
  • [27] Endo-lysosomal dysregulations and late-onset Alzheimer's disease: impact of genetic risk factors
    Van Acker, Zoe P.
    Bretou, Marine
    Annaert, Wim
    [J]. MOLECULAR NEURODEGENERATION, 2019, 14 (1)
  • [28] Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors
    Zoë P. Van Acker
    Marine Bretou
    Wim Annaert
    [J]. Molecular Neurodegeneration, 14
  • [29] Plasma β-amyloid as a surrogate genetic marker in late-onset Alzheimer's disease
    Ertekin-Taner, N
    Graff-Radford, N
    Younkin, LH
    Eckman, C
    Adamson, J
    Schaid, DJ
    Blangero, J
    Hutton, M
    Younkin, SG
    [J]. ALZHEIMER'S DISEASE: ADVANCES IN ETIOLOGY, PATHOGENESIS AND THERAPEUTICS, 2001, : 303 - 310
  • [30] Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups
    Shubhabrata Mukherjee
    Jesse Mez
    Emily H. Trittschuh
    Andrew J. Saykin
    Laura E. Gibbons
    David W. Fardo
    Madeline Wessels
    Julianna Bauman
    Mackenzie Moore
    Seo-Eun Choi
    Alden L. Gross
    Joanne Rich
    Diana K. N. Louden
    R. Elizabeth Sanders
    Thomas J. Grabowski
    Thomas D. Bird
    Susan M. McCurry
    Beth E. Snitz
    M. Ilyas Kamboh
    Oscar L. Lopez
    Philip L. De Jager
    David A. Bennett
    C. Dirk Keene
    Eric B. Larson
    Paul K. Crane
    [J]. Molecular Psychiatry, 2020, 25 : 2942 - 2951